EOLS – Evolus, Inc.
Evolus, Inc. Common StockEOLS
$7.68Name : Evolus, Inc. Common Stock
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $496,783,872.00
EPSttm : -0.97
Evolus, Inc. Common Stock
$7.68
3.43%$0.255Float Short %
24.63
Margin Of Safety %
Put/Call OI Ratio
1.24
EPS Next Q Diff
0.37
EPS Last/This Y
0.26
EPS This/Next Y
0.7
Price
7.69
Target Price
19
Analyst Recom
1.29
Performance Q
-19.67
Relative Volume
0.95
Beta
1.1
Ticker: EOLS
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | EOLS | 9.53 | 0.06 | 0.03 | 7999 |
| 2025-07-28 | EOLS | 9.28 | 0.08 | 0.03 | 7281 |
| 2025-07-29 | EOLS | 9.26 | 0.08 | 0.49 | 7291 |
| 2025-07-30 | EOLS | 8.97 | 0.08 | 0.12 | 7301 |
| 2025-07-31 | EOLS | 8.93 | 0.09 | 0.00 | 7460 |
| 2025-08-01 | EOLS | 9.15 | 0.09 | 25.42 | 7588 |
| 2025-08-04 | EOLS | 9.11 | 0.80 | 0.09 | 12798 |
| 2025-08-05 | EOLS | 8.93 | 0.78 | 5.99 | 13022 |
| 2025-08-06 | EOLS | 6.37 | 0.91 | 7.22 | 14235 |
| 2025-08-07 | EOLS | 6.07 | 1.36 | 0.20 | 19357 |
| 2025-08-08 | EOLS | 5.91 | 1.31 | 0.23 | 19588 |
| 2025-08-11 | EOLS | 5.76 | 1.27 | 0.00 | 19758 |
| 2025-08-12 | EOLS | 6.39 | 1.21 | 0.00 | 20214 |
| 2025-08-13 | EOLS | 6.52 | 1.19 | 0.00 | 20345 |
| 2025-08-14 | EOLS | 6.4 | 1.18 | 0.00 | 20393 |
| 2025-08-15 | EOLS | 6.72 | 1.13 | 1.06 | 20824 |
| 2025-08-18 | EOLS | 6.7 | 1.23 | 0.00 | 19047 |
| 2025-08-19 | EOLS | 7.14 | 1.23 | 0.07 | 19048 |
| 2025-08-20 | EOLS | 7.24 | 1.24 | 0.32 | 19029 |
| 2025-08-21 | EOLS | 7.43 | 1.23 | 0.14 | 19045 |
| 2025-08-22 | EOLS | 7.68 | 1.24 | 0.08 | 19028 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | EOLS | 9.53 | -42.6 | 12.4 | -0.13 |
| 2025-07-28 | EOLS | 9.30 | -42.6 | 12.7 | -0.13 |
| 2025-07-29 | EOLS | 9.25 | -42.6 | 12.2 | -0.13 |
| 2025-07-30 | EOLS | 8.96 | -42.6 | 12.8 | -0.13 |
| 2025-07-31 | EOLS | 8.92 | -42.6 | 12.2 | -0.13 |
| 2025-08-01 | EOLS | 9.15 | -47.9 | 11.5 | -0.13 |
| 2025-08-04 | EOLS | 9.11 | -47.9 | 12.2 | -0.13 |
| 2025-08-05 | EOLS | 8.91 | -47.9 | 12.6 | -0.13 |
| 2025-08-06 | EOLS | 6.36 | -47.9 | 18.6 | -0.13 |
| 2025-08-07 | EOLS | 6.07 | -47.9 | 16.3 | -0.13 |
| 2025-08-08 | EOLS | 5.90 | -47.9 | 13.0 | -0.48 |
| 2025-08-11 | EOLS | 5.76 | 12.3 | 12.9 | -0.48 |
| 2025-08-12 | EOLS | 6.40 | 12.3 | 9.9 | -0.48 |
| 2025-08-13 | EOLS | 6.51 | 12.3 | 12.0 | -0.48 |
| 2025-08-14 | EOLS | 6.40 | 12.3 | 12.7 | -0.48 |
| 2025-08-15 | EOLS | 6.72 | 12.3 | 11.2 | -0.55 |
| 2025-08-18 | EOLS | 6.70 | 12.3 | 12.5 | -0.55 |
| 2025-08-19 | EOLS | 7.13 | 12.3 | 10.9 | -0.55 |
| 2025-08-20 | EOLS | 7.24 | 12.3 | 12.0 | -0.55 |
| 2025-08-21 | EOLS | 7.43 | 12.3 | 11.7 | -0.55 |
| 2025-08-22 | EOLS | 7.69 | 12.3 | 11.5 | -0.55 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | EOLS | -3.84 | 5.11 | 22.15 |
| 2025-07-28 | EOLS | -3.84 | 4.25 | 22.15 |
| 2025-07-29 | EOLS | -3.84 | 4.25 | 22.15 |
| 2025-07-30 | EOLS | -3.84 | 4.25 | 22.15 |
| 2025-07-31 | EOLS | -3.84 | 4.25 | 22.15 |
| 2025-08-01 | EOLS | -3.84 | 4.25 | 22.15 |
| 2025-08-04 | EOLS | -3.84 | 4.39 | 22.15 |
| 2025-08-05 | EOLS | -3.84 | 4.39 | 22.15 |
| 2025-08-06 | EOLS | -3.84 | 4.39 | 22.15 |
| 2025-08-07 | EOLS | -3.84 | 4.39 | 22.15 |
| 2025-08-08 | EOLS | -3.83 | 4.39 | 22.08 |
| 2025-08-11 | EOLS | -3.83 | 4.41 | 22.08 |
| 2025-08-12 | EOLS | -3.83 | 4.41 | 23.56 |
| 2025-08-13 | EOLS | -3.83 | 4.41 | 23.56 |
| 2025-08-14 | EOLS | -3.83 | 4.41 | 23.56 |
| 2025-08-15 | EOLS | -3.83 | 4.41 | 23.56 |
| 2025-08-18 | EOLS | -3.46 | 3.43 | 24.63 |
| 2025-08-19 | EOLS | -2.62 | 3.43 | 24.63 |
| 2025-08-20 | EOLS | -2.62 | 3.43 | 24.63 |
| 2025-08-21 | EOLS | -2.62 | 3.43 | 24.63 |
| 2025-08-22 | EOLS | -2.62 | 3.43 | 24.63 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.3
Avg. EPS Est. Current Quarter
-0.16
Avg. EPS Est. Next Quarter
0.07
Insider Transactions
-2.62
Institutional Transactions
3.43
Beta
1.1
Average Sales Estimate Current Quarter
67
Average Sales Estimate Next Quarter
91
Fair Value
Quality Score
31
Growth Score
52
Sentiment Score
76
Actual DrawDown %
56.9
Max Drawdown 5-Year %
-68.4
Target Price
19
P/E
Forward P/E
26.35
PEG
P/S
1.79
P/B
P/Free Cash Flow
EPS
-0.97
Average EPS Est. Cur. Y
-0.55
EPS Next Y. (Est.)
0.15
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-22.31
Relative Volume
0.95
Return on Equity vs Sector %
307.7
Return on Equity vs Industry %
324.5
EPS 1 7Days Diff
-0.4
EPS 1 30Days Diff
-0.42
EBIT Estimation
11.5
Evolus, Inc. Common StockSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 394
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
stock quote shares EOLS – Evolus, Inc. Stock Price stock today
news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EOLS – Evolus, Inc. yahoo finance google finance
stock history EOLS – Evolus, Inc. invest stock market
stock prices EOLS premarket after hours
ticker EOLS fair value insiders trading